Grant Review Process
Lyme Research Alliance (LRA) has modeled its grants division after that of the National Institutes of Health. LRA parallels the RO1 and RO3 grant categories in this way:
1. Research project grants:
Duration of one year
No monetary limit; may be funded fully or partially
Renewable by request and by reasonable fulfillment of previous scope of work
2. Small project grants
Duration 6 months to one year
$10,000-50,000 awards used as "seed" money or for focused, short
term scope of work
The Grant Review Committee (GRC) of the Scientific Advisory Board is responsible for grant reviews. The Financial Review Committee (FRC) is available to advise in the event of any conflicts of interest or issues of commercial application. Once again, the process parallels that of the NIH. The Chief Scientific Officer is the "intake" person, who assures that the application is complete and is sent to the GRC.
The GRC evaluates both quantitatively and qualitatively. An overall quantitative score is given on a scale of 1 to 10: 1--strong, nearly flawless application; 5--average application; 10--poor application with major shortfalls.
Reviewers comment on several aspects of the application:
- Significance or impact of the study to drive the science concerning Lyme and other tick-borne diseases forward
- Expertise and previous rate of success of principal investigator and collaborators
- Innovation supported by fact-based concepts, methods
- Compatibility of the scope of work to the specific goals of the project/compatibility of the scope of work to the proposed budget
- Appropriate scientific environment
GRC members are experts in their fields. Should additional peer review be necessary, grant applications are sent to esteemed members of LRA’s peer review board. Reviews are conducted double-blind.
Once the entire grant review process is completed, the committee meets to discuss and prioritize the grant application list in conjunction with the monies available, as assigned by the LRA Executive Committee. The GRC makes its recommendations to the LRA Board of Directors, by whom a final decision is given following majority approval of these recommendations.
All grant recipients are required to sign a Research Grant Agreement, created to protect both the grant recipient(s) and LRA. These agreements are tailored to each, individual grant and are subject to negotiation. Monies are only awarded to a medical institution, foundation, or university, never to an individual.
Grant Application Deadlines
The most recent grant application period closed April 15. New grant awards will be posted on this site by May 30. The application may be downloaded and returned to Dr. Harriet Kotsoris, Chief Scientific Officer, at hkotsoris@LymeResearchAlliance.org.